Clopidogrel Bisulfate is a thienopyridine-class antiplatelet agent that inhibits platelet aggregation by selectively and irreversibly binding to the P2Y12 adenosine diphosphate (ADP) receptor on platelets. It is commonly used to reduce the risk of heart disease and stroke in patients with a history of cardiovascular events. Clopidogrel bisulfate and Clopidogrel hydrogen sulfate are essentially the same but in different names for the same chemical compound, which is a salt form of the antiplatelet drug clopidogrel. The name "bisulfate" is a less formal way of saying hydrogen sulfate.
Clopidogrel Bisulfate is a thienopyridine-class antiplatelet agent that inhibits platelet aggregation by selectively and irreversibly binding to the P2Y12 adenosine diphosphate (ADP) receptor on platelets. It is commonly used to reduce the risk of heart disease and stroke in patients with a history of cardiovascular events. Clopidogrel bisulfate and Clopidogrel hydrogen sulfate are essentially the same but in different names for the same chemical compound, which is a salt form of the antiplatelet drug clopidogrel. The name "bisulfate" is a less formal way of saying hydrogen sulfate.
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
Included in Quote
Included in Quote
Included in Quote
Included in Quote
.7767eb0f.png)
Chemical Properties & Specifications
Prevention of atherothrombotic events in patients with acute coronary syndrome, recent myocardial infarction, or established peripheral arterial disease.
Reduction of stroke risk in patients with a history of recent stroke or established cerebrovascular disease.
Used as a reference standard in pharmaceutical research and quality control.
It works by irreversibly inhibiting the P2Y12 ADP receptor on platelets, preventing platelet activation and aggregation, thereby reducing the risk of blood clot formation.
Common side effects include bleeding, bruising, diarrhea, rash, and itching. Severe effects may include gastrointestinal bleeding, allergic reactions, or thrombotic thrombocytopenic purpura (TTP).
Clopidogrel Bisulfate can interact with medications such as proton pump inhibitors (e.g., omeprazole), NSAIDs, warfarin, and SSRIs. Always inform your healthcare provider about any medications you are taking.
Yes, it is generally considered safe for long-term use, but regular monitoring is necessary to assess for potential bleeding risks or other adverse effects.
The safety of Clopidogrel Bisulfate during pregnancy is not well established. It should only be used if clearly necessary and under medical supervision.
Store at room temperature (15–30°C), protected from light and moisture, in a tightly closed container.
The usual adult dosage is 75 mg once daily, with or without food, as prescribed by a healthcare provider. Dosage may vary depending on medical condition and patient response.
Complies with USP and EP specifications.
Compliant with EU REACH regulations.
